ABSTRACT

Discussion:

PPV procedure has favorable effects on the anatomical and visual prognosis in eyes with PDR. PPV improves visual acuity better in eyes without TRD than that with PDR.

Results:

Mean follow up time was 6.3 ± 3.9 (± SEM) months (range, 3-15 months). The most common indication for PPV was persistent vitreous hemorrhage (n=21, 50%). Eighteen patients (43%) underwent PPV for tractional retinal detachment (TRD) and/or tractional macu-lar detachment (TMD) with vitreous hemorrhage. Final visual acuity after PPV increased at le-ast 1 Snellen line in 67% of patients, decreased in 10% of patients, remained stable in 24% of patients. The most common complications during operation were retinal microhemorrhage (5%) and iatrogenic retinal detachment (5%). The most common complication reported at early postoperative examinations was transiently increased intraocular pressure (14%). Cataract develop-ment was detected in 26% of patients during late postoperative examinations. Postoperative Snellen visual acuity (0.13 ± 0.05) after PPV in eyes with TRD was lower than that of (0.20 ± 0.05) eyes without PDR (P=0.04). Factors which did not effect final visual acuity were type of diabetes mellitus (P=0.07), sex (P=0.11), preoperative panretinal photocoagulation (P=0.79) and tamponade type used during operation (P=0.26).

Material and Methods:

Forty two eyes of 42 patients (mean age 57 years) who underwent PPV for proliferative diabetic retinopathy (PDR) were included in this study. Pre- and postoperative visual acuity, anterior and posterior segment examination findings and peroperative and postoperative complications were recorded.

Purpose:

To investigate the factors which affect postoperative visual acuity in patients un-derwent pars plana vitrectomy (PPV) for diabetic retinopathy.

References

1Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care 1992;15:1875-1891.

2Aiello LM. Perspectives on diabetic retinopathy. Am J Ophthalmol 2003;136:122-135.

3Porta M. Diabetic retinopathy and metabolic control. Eur J Ophthalmol 1993;3:207-215.

4Hasanreisoglu B, Bilgihan K, Akbatur HH, Akata F, Or M. 379 proliferatif diabetik retinopati olgusunda vitrektomi, komplikasyonlar ve sonuçlar. Ret-Vit 1993;1: 44-48.

5Aaberg TM, Abrams GW. Changing indications and techniques for vitrectomy in management of complications of diabetic retinopathy. Ophthalmology 1987;94:775-779.

6Bardak Y, Çekiç O, Tıg UŞ. Proliferatif diyabetik retinopatide pars plana vitrektomi ile kombine fakoemülsifikasyon-pars plana vitrektomi uygulamalarının karşılaştırılması. Ret-Vit 2006;14:133-136.

7Özertürk Y, Erşanlı D, Durmuş M. Proliferatif diyabetik retinopatide prognozu etkileyen komplikasyonlar ve vitrektominin etkisi. Ret-Vit 1998;6:46-49.

8Bardak Y, Tıg UŞ, Çekiç O, Kendir F. Proliferatif diabetik retinopatide pars plana vitrektomi sonuçlarımız. Retina-Vitreus 2006;14:275-80.

9Kolsal M, Avcı R, Baykara M, Gelişken Ö. Proliferatif diabetik retinopatide pars plana vitrektomi. Ret-Vit 1998;6: 220-227.

10Sigurdsson H, Baines PS, Roxburgh ST. Vitrectomy for diabetic eye disease. Eye 1988;2:418-423.

11Machemer R, Blankenship G. Vitrectomy for proliferative diabetic retinopathy associated with vitreous hemorrhage. Ophthalmology 1981;88:643-636.

12American Academy of Ophthalmology. Retina and Vitreous. In: Hecht KA (ed): Basic and Clinical Science Course 1990-91. San Francisco, California. 1990, Vol 4:14-24.

13Laatikainen L, Summanen P. Long-term visual results of vitreous surgery in diabetic eye disease. Acta Ophthalmol 1989;67:21-29.

14de Bustros S, Thompson JT, Michels RG, Rice TA. Vitrectomy for progressive proliferative diabetic retinopathy. Arch Ophthalmol 1987;105:196-199.

15Flynn HW Jr, Chew EY, Simons BD, Barton FB, Remaley NA, Ferris FL 3rd. Pars plana vitrectomy in the Early

16Treatment Diabetic Retinopathy Study. ETDRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1992;99: 1351-1357.

17 Kır N. Diabetik retinopatide pars plana vitrektomi sonuçları. T Oft Gaz 2001;31:638-643.

18Eldem B, Oruç S. Pars plana vitrektomi sonuçları. Andaç K, Menteş J, Yagcı A, ve ark (Ed.ler): TOD XXVII. Ulus Kong Bült (1993), Cilt II. S: 1117- 23, İzmir:Yeniyol Matbaası, 1994.

19Ramsay RC, Knobloch WH, Cantrill HL. Timing of vitrectomy for active proliferative diabetic retinopathy. Ophthalmology 1986;93:283-289.

20Diabetic Retinopathy Vitrectomy Study Report 5. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial. Arch Ophthalmol 1990;108:958-964.

21Ünlü N, Acar MA, Kocaoglan H, Yılmaz G, Aslan BS, Duman S. Proliferatif diabetik retinopati komplikasyonları nda vitrektomi. T Oft Gaz 2002;32:374-379.

22Chaudhry NA, Lim ES, Saito Y, Mieler WF, Liggett PE, Filatov V. Early vitrectomy and endolaser photocoagulation in patients with type I diabetes with severe vitreous hemorrhage. Ophthalmology 1995;102:1164-1169.

23Meier P, Wiedemann P. Vitrectomy for tractional macular detachment in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 1997;235:569-574.

24Castellarin A, Grigorian R, Bhagat N, Del Priore L, Zarbin MA. Vitrectomy with silicone oil infusion in severe diabetic retinopathy. Br J Ophthalmol 2003;87:318-321.

25Braunstein RE, Airiani S. Cataract surgery results after pars plana vitrectomy. Curr Opin Ophthalmol 2003;14:150-154.

26Biro Z, Kovacs B. Results of cataract surgery in previously vitrectomized eyes. J Cataract Refract Surg 2002;28:1003-1006.

27Schachat AP, Oyakawa RT, Michels RG, Rice TA. Complications of vitreous surgery for diabetic retinopathy. Postoperative complications. Ophthalmology 1983; 90:522-530.

Factors Which Effect Final Visual Acuity In Eyes With Proliferative Diabetic Retinopathy That Underwent Pars Plana Vitrectomy

ABSTRACT

References